INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECH MEDICALE) has a total of 26 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are UNIV LAUSANNE, RES DEV FOUNDATION and RSEM LTD PARTNERSHIP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | Dominican Republic | 1 | |
#6 | France | 1 | |
#7 | Peru | 1 | |
#8 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Medical technology | |
#5 | Foods and drinks | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Physical therapy devices | |
#9 | Diagnosis and surgery | |
#10 | Steroids |
# | Name | Total Patents |
---|---|---|
#1 | Olive Daniel | 2 |
#2 | Piazza Pier Vincenzo | 2 |
#3 | Hernandez Alfredo | 2 |
#4 | Revest Jean-Michel | 2 |
#5 | Vallee Monique | 2 |
#6 | Felpin Francois-Xavier | 2 |
#7 | Garbar Christian | 1 |
#8 | Nordmann Patrice | 1 |
#9 | Mallet Jacques | 1 |
#10 | Aboulker Jean-Pierre | 1 |
Publication | Filing date | Title |
---|---|---|
US2020254069A1 | Compositions for treating macular edema | |
WO2017207656A1 | Atp6ap2 inhibition for treating or preventing a tumoural and/or proliferative disorder of the central nervous system | |
CA2991077A1 | Methods for obtaining regulatory t cells and uses thereof | |
US2017319661A1 | Methods and Pharmaceutical Compositions Using Orexins (OXA, OXB) for the Treatment of Prostate Cancers | |
US2017020847A1 | Methods and pharmaceutical compositions for the treatment of beta-thalassemias |